{"resourceType": "Citation", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/journal-article-citation"], "versionId": "11", "lastUpdated": "2025-10-12T09:15:30.172Z"}, "contained": [{"resourceType": "Practitioner", "id": "contributor0", "name": [{"family": "Widmark", "given": ["Anders"]}]}, {"resourceType": "Practitioner", "id": "contributor1", "name": [{"family": "Klepp", "given": ["Olbj\u00f8rn"]}]}, {"resourceType": "Practitioner", "id": "contributor2", "name": [{"family": "Solberg", "given": ["Arne"]}]}, {"resourceType": "Practitioner", "id": "contributor3", "name": [{"family": "Damber", "given": ["Jan-Erik"]}]}, {"resourceType": "Practitioner", "id": "contributor4", "name": [{"family": "Angelsen", "given": ["Anders"]}]}, {"resourceType": "Practitioner", "id": "contributor5", "name": [{"family": "Fransson", "given": ["Per"]}]}, {"resourceType": "Practitioner", "id": "contributor6", "name": [{"family": "Lund", "given": ["Jo-Asmund"]}]}, {"resourceType": "Practitioner", "id": "contributor7", "name": [{"family": "Tasdemir", "given": ["Ilker"]}]}, {"resourceType": "Practitioner", "id": "contributor8", "name": [{"family": "Hoyer", "given": ["Morten"]}]}, {"resourceType": "Practitioner", "id": "contributor9", "name": [{"family": "Wiklund", "given": ["Fredrik"]}]}, {"resourceType": "Practitioner", "id": "contributor10", "name": [{"family": "Foss\u00e5", "given": ["Sophie D"]}]}, {"resourceType": "Organization", "id": "contributor11", "name": "Scandinavian Prostate Cancer Group Study 7"}, {"resourceType": "Organization", "id": "contributor12", "name": "Swedish Association for Urological Oncology 3"}, {"resourceType": "ArtifactAssessment", "id": "meshHeading0", "artifactReference": {"reference": "#", "type": "Citation"}, "content": [{"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D000368", "display": "Aged", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D000726", "display": "Androgen Antagonists", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000627", "display": "therapeutic use"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49488", "display": "Yes"}]}]}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D003131", "display": "Combined Modality Therapy", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D005485", "display": "Flutamide", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000627", "display": "therapeutic use"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49488", "display": "Yes"}]}]}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D006801", "display": "Humans", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D008297", "display": "Male", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D011468", "display": "Prostatectomy", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D011471", "display": "Prostatic Neoplasms", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000188", "display": "drug therapy"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49488", "display": "Yes"}]}]}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000401", "display": "mortality"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49487", "display": "No"}]}]}]}, {"type": {"text": "qualifier"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "Q000532", "display": "radiotherapy"}]}], "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code": "C49488", "display": "Yes"}]}]}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D012720", "display": "Severity of Illness Index", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}, {"type": {"coding": [{"system": "http://hl7.org/fhir/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}], "text": "components (if present) include qualifier codings"}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016019", "display": "Survival Analysis", "userSelected": false}]}], "freeToShare": true, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}]}]}], "useContext": [{"code": {"system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "code": "fevir-platform-use", "display": "FEvIR Platform Use"}, "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "code": "medline-base", "display": "Medline Base", "userSelected": false}]}}], "classification": [{"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "code": "citation-source", "display": "Citation Source"}]}, "classifier": [{"text": "MEDLINE"}]}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "code": "medline-owner", "display": "MEDLINE Citation Owner"}]}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#owner_value", "code": "NLM", "display": "National Library of Medicine, Index Section", "userSelected": false}]}]}], "statusDate": [{"activity": {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-pubstatus-entrez", "display": "PubMed Pubstatus of Entrez"}]}, "period": {"end": "2008-12-19T09:00:00.000Z"}}, {"activity": {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-pubstatus-pubmed", "display": "PubMed Pubstatus of Pubmed"}]}, "period": {"end": "2008-12-19T09:00:00.000Z"}}, {"activity": {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-pubstatus-medline", "display": "PubMed Pubstatus of Medline"}]}, "period": {"end": "2009-02-06T09:00:00.000Z"}}], "citedArtifact": {"identifier": [{"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "19091394"}, {"system": "https://doi.org", "value": "10.1016/S0140-6736(08)61815-2"}, {"type": {"text": "pii", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "S0140-6736(08)61815-2"}], "relatedIdentifier": [{"assigner": {"display": "ISRCTN"}, "value": "ISRCTN01534787"}], "title": [{"text": "Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.", "language": {"coding": [{"system": "urn:ietf:bcp:47", "code": "en", "display": "English"}]}, "type": [{"coding": [{"system": "http://terminology.hl7.org/CodeSystem/title-type", "code": "primary", "display": "Primary title"}]}]}], "abstract": [{"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-aritfact-abstract-type", "code": "primary-human-use", "display": "Primary human use"}]}, "text": "**BACKGROUND:** Several studies have shown the efficacy of endocrine therapy in combination with radiotherapy in high-risk prostate cancer. To assess the effect of radiotherapy, we did an open phase III study comparing endocrine therapy with and without local radiotherapy, followed by castration on progression.\n**METHODS:** This randomised trial included men from 47 centres in Norway, Sweden, and Denmark. Between February, 1996, and December, 2002, 875 patients with locally advanced prostate cancer (T3; 78%; PSA&lt;70; N0; M0) were centrally randomly assigned by computer to endocrine treatment alone (3 months of total androgen blockade followed by continuous endocrine treatment using flutamide; 439 patients), or to the same endocrine treatment combined with radiotherapy (436 patients). The primary endpoint was prostate-cancer-specific survival, and analysis was by intention to treat. This study is registered as an international standard randomised controlled trial, number ISRCTN01534787.\n**FINDINGS:** After a median follow-up of 7.6 years, 79 men in the endocrine alone group and 37 men in the endocrine plus radiotherapy group had died of prostate cancer. The cumulative incidence at 10 years for prostate-cancer-specific mortality was 23.9% in the endocrine alone group and 11.9% in the endocrine plus radiotherapy group (difference 12.0%, 95% CI 4.9-19.1%), for a relative risk of 0.44 (0.30-0.66). At 10 years, the cumulative incidence for overall mortality was 39.4% in the endocrine alone group and 29.6% in the endocrine plus radiotherapy group (difference 9.8%, 0.8-18.8%), for a relative risk of 0.68 (0.52-0.89). Cumulative incidence at 10 years for PSA recurrence was substantially higher in men in the endocrine-alone group (74.7%vs 25.9%, p&lt;0.0001; HR 0.16; 0.12-0.20). After 5 years, urinary, rectal, and sexual problems were slightly more frequent in the endocrine plus radiotherapy group.\n**INTERPRETATION:** In patients with locally advanced or high-risk local prostate cancer, addition of local radiotherapy to endocrine treatment halved the 10-year prostate-cancer-specific mortality, and substantially decreased overall mortality with fully acceptable risk of side-effects compared with endocrine treatment alone. In the light of these data, endocrine treatment plus radiotherapy should be the new standard."}], "relatesTo": [{"type": "correction-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016425", "display": "Published Erratum", "userSelected": false}]}], "citation": "Lancet. 2009 Apr 4;373(9670):1174"}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "Lancet. 2009 Jan 24;373(9660):274-6. doi: 10.1016/S0140-6736(08)61816-4.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "19091392", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/19091392/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "Nat Rev Urol. 2009 May;6(5):250-1. doi: 10.1038/nrurol.2009.56.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "19424171", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/19424171/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "Ann Intern Med. 2009 Jun 16;150(12):JC6-6. doi: 10.7326/0003-4819-150-12-200906160-02006.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "19528551", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/19528551/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "Eur Urol. 2009 May;55(5):1240. doi: 10.1016/j.eururo.2009.01.059.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "19650206", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/19650206/"}}, {"type": "comment-in", "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016420", "display": "Comment", "userSelected": false}]}], "citation": "Eur Urol. 2009 May;55(5):1239-40. doi: 10.1016/j.eururo.2009.01.058.", "targetReference": {"identifier": {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "19650231", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/19650231/"}}], "publicationForm": [{"publishedIn": {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/published-in-type", "code": "D020492", "display": "Periodical"}]}, "identifier": [{"type": {"coding": [{"system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#issn", "code": "Electronic", "display": "Electronic"}], "text": "Electronic ISSN Type"}, "value": "1474-547X", "system": "https://portal.issn.org"}, {"type": {"text": "ISOAbbreviation", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "system": "https://www.issn.org/services/online-services/access-to-the-ltwa/", "value": "Lancet"}, {"type": {"text": "ISSN Linking", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "system": "https://www.issn.org/understanding-the-issn/assignment-rules/the-issn-l-for-publications-on-multiple-media/", "value": "0140-6736"}, {"type": {"text": "Medline Title Abbreviation", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "system": "https://www.nlm.nih.gov/tsd/cataloging/contructitleabbre.html", "value": "Lancet"}, {"type": {"text": "NLM Unique ID", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "system": "https://locatorplus.gov/cgi-bin/Pwebrecon.cgi?DB=local", "value": "2985213R"}], "title": "Lancet (London, England)", "publisherLocation": "England"}, "citedMedium": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-medium", "code": "internet", "display": "Internet"}]}, "volume": "373", "issue": "9660", "articleDate": "2009-01-24", "pageString": "301-8", "publicationDateText": "2009-Jan-24"}, {"citedMedium": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-medium", "code": "internet-without-issue", "display": "Internet without issue"}]}, "articleDate": "2008-12-16"}], "webLocation": [{"classifier": [{"coding": [{"system": "http://terminology.hl7.org/CodeSystem/artifact-url-classifier", "code": "abstract", "display": "Abstract"}]}], "url": "https://pubmed.ncbi.nlm.nih.gov/19091394/"}, {"url": "https://doi.org/10.1016/S0140-6736(08)61815-2", "classifier": [{"coding": [{"system": "http://terminology.hl7.org/CodeSystem/artifact-url-classifier", "code": "doi-based", "display": "DOI Based"}]}]}], "classification": [{"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code": "publishing-model", "display": "Publishing Model", "userSelected": false}]}, "classifier": [{"coding": [{"system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "code": "Print-Electronic", "display": "Print Electronic", "userSelected": false}]}]}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code": "chemical", "display": "Chemical", "userSelected": false}]}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D000726", "display": "Androgen Antagonists", "userSelected": false}]}, {"coding": [{"system": "https://www.cas.org/support/documentation/chemical-substances", "code": "76W6J0943E", "userSelected": false}, {"system": "https://www.nlm.nih.gov/mesh", "code": "D005485", "display": "Flutamide", "userSelected": false}]}]}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code": "mesh-heading", "display": "MeSH heading"}]}, "artifactAssessment": [{"reference": "#meshHeading0", "type": "ArtifactAssessment"}]}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code": "publication-type", "display": "Publication type"}]}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D017428", "display": "Clinical Trial, Phase III", "userSelected": false}]}, {"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016428", "display": "Journal Article", "userSelected": false}]}, {"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016448", "display": "Multicenter Study", "userSelected": false}]}, {"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D016449", "display": "Randomized Controlled Trial", "userSelected": false}]}, {"coding": [{"system": "https://www.nlm.nih.gov/mesh", "code": "D013485", "display": "Research Support, Non-U.S. Gov't", "userSelected": false}]}]}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code": "knowledge-artifact-type", "display": "Knowledge Artifact Type", "userSelected": false}]}, "classifier": [{"coding": [{"system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "code": "D016428", "display": "Journal Article", "userSelected": false}]}], "artifactAssessment": [{"display": "Classifier added by Computable Publishing LLC"}]}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code": "citation-subset", "display": "Citation subset", "userSelected": false}]}, "classifier": [{"coding": [{"system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#citationsubset", "code": "IM", "display": "IM", "userSelected": false}]}]}], "contributorship": {"entry": [{"contributor": {"reference": "#contributor0", "type": "Practitioner", "display": "Widmark A"}, "forenameInitials": "A", "affiliation": [{"display": "Department of Radiation Sciences, Oncology, Ume\u00e5 University, Ume\u00e5, Sweden."}]}, {"contributor": {"reference": "#contributor1", "type": "Practitioner", "display": "Klepp O"}, "forenameInitials": "O"}, {"contributor": {"reference": "#contributor2", "type": "Practitioner", "display": "Solberg A"}, "forenameInitials": "A"}, {"contributor": {"reference": "#contributor3", "type": "Practitioner", "display": "Damber JE"}, "forenameInitials": "JE"}, {"contributor": {"reference": "#contributor4", "type": "Practitioner", "display": "Angelsen A"}, "forenameInitials": "A"}, {"contributor": {"reference": "#contributor5", "type": "Practitioner", "display": "Fransson P"}, "forenameInitials": "P"}, {"contributor": {"reference": "#contributor6", "type": "Practitioner", "display": "Lund JA"}, "forenameInitials": "JA"}, {"contributor": {"reference": "#contributor7", "type": "Practitioner", "display": "Tasdemir I"}, "forenameInitials": "I"}, {"contributor": {"reference": "#contributor8", "type": "Practitioner", "display": "Hoyer M"}, "forenameInitials": "M"}, {"contributor": {"reference": "#contributor9", "type": "Practitioner", "display": "Wiklund F"}, "forenameInitials": "F"}, {"contributor": {"reference": "#contributor10", "type": "Practitioner", "display": "Foss\u00e5 SD"}, "forenameInitials": "SD"}, {"contributor": {"reference": "#contributor11", "type": "Organization", "display": "Scandinavian Prostate Cancer Group Study 7"}}, {"contributor": {"reference": "#contributor12", "type": "Organization", "display": "Swedish Association for Urological Oncology 3"}}], "complete": true}}, "approvalDate": "2009-02-05", "lastReviewDate": "2022-03-30", "currentState": [{"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "medline-medline", "display": "Medline Citation Status of Medline"}]}, {"coding": [{"system": "http://hl7.org/fhir/citation-status-type", "code": "pubmed-publication-status-ppublish", "display": "PubMed PublicationStatus of ppublish"}]}], "title": "19091394 Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net/FOI", "value": "179627", "assigner": {"display": "Computable Publishing LLC"}}, {"system": "https://pubmed.ncbi.nlm.nih.gov", "value": "19091394"}], "status": "active", "url": "https://fevir.net/resources/Citation/179627", "id": "179627", "publisher": "Computable Publishing LLC", "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "contact": [{"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}], "author": [{"name": "Computable Publishing\u00ae: MEDLINE-to-FEvIR Converter"}], "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "code": "active", "display": "Active"}]}}], "description": "This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide."}